Curanex Pharmaceuticals
CURX
10 hedge funds and large institutions have $206K invested in Curanex Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
1.03% more ownership
Funds ownership: 0% → 1.03% (+1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$292K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$290K |
| 3 |
Jane Street
New York
|
+$160K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$147K |
| 5 |
JF
Jump Financial
Chicago,
Illinois
|
+$123K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $46.5K | +$292K | +64,516 | New |
|
|
2
Citadel Advisors
Miami,
Florida
| $46.1K | +$290K | +64,067 | New |
|
|
3
Jane Street
New York
| $25.4K | +$160K | +35,277 | New |
|
|
TSS
4
Two Sigma Securities
New York
| $23.4K | +$147K | +32,435 | New |
|
|
JF
5
Jump Financial
Chicago,
Illinois
| $19.6K | +$123K | +27,200 | New |
|
6
Millennium Management
New York
| $13.8K | +$86.7K | +19,154 | New |
|
7
Geode Capital Management
Boston,
Massachusetts
| $13.4K | +$84.5K | +18,670 | New |
|
|
SRL
8
Scientech Research LLC
Jersey City,
New Jersey
| $10.4K | +$65.5K | +14,480 | New |
|
9
Osaic Holdings
Scottsdale,
Arizona
| $4.45K | +$25.8K | +5,700 | New |
|
10
Barclays
London,
United Kingdom
| $3.31K | +$20.8K | +4,594 | New |
|
CURX Hedge Fund Activity: Q3 2025 in Review
10 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Curanex Pharmaceuticals (CURX) for Q3 2025, worth a combined $206K.
Buyers outnumbered sellers: 10 funds opened new CURX positions and 0 closed out — a net gain of 10 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $292K.
- 10 institutional investors held Curanex Pharmaceuticals (CURX) as of Q3 2025, up from 0 in Q2 2025.
- Funds reported $206K of Curanex Pharmaceuticals stock for Q3 2025.
- 10 funds opened new Curanex Pharmaceuticals positions in Q3 2025 and 0 closed out, a net change of +10 holders.
- The largest Curanex Pharmaceuticals buyer in Q3 2025 was UBS Group, an estimated $292K added.
Based on aggregated 13F filings for Q3 2025.